IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 112 filers reported holding IMMUNOMEDICS INC in Q2 2016. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $829,000 | +129.0% | 9,737 | -4.7% | 0.00% | – |
Q2 2020 | $362,000 | +289.2% | 10,214 | +48.6% | 0.00% | – |
Q1 2020 | $93,000 | -34.0% | 6,875 | +3.1% | 0.00% | – |
Q4 2019 | $141,000 | +131.1% | 6,671 | +45.8% | 0.00% | – |
Q3 2019 | $61,000 | -3.2% | 4,575 | 0.0% | 0.00% | – |
Q2 2019 | $63,000 | -97.6% | 4,575 | -96.7% | 0.00% | -100.0% |
Q1 2019 | $2,629,000 | +3944.6% | 136,866 | +2886.4% | 0.00% | – |
Q4 2018 | $65,000 | -47.6% | 4,583 | -23.0% | 0.00% | – |
Q3 2018 | $124,000 | -4.6% | 5,950 | +8.3% | 0.00% | – |
Q2 2018 | $130,000 | -83.8% | 5,496 | -90.0% | 0.00% | -100.0% |
Q1 2018 | $802,000 | +771.7% | 54,894 | +859.5% | 0.00% | – |
Q4 2017 | $92,000 | +283.3% | 5,721 | +232.4% | 0.00% | – |
Q3 2017 | $24,000 | +1100.0% | 1,721 | +141.0% | 0.00% | – |
Q2 2016 | $2,000 | – | 714 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |